Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Growth Hormone-Secreting Pituitary Adenoma"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 263
Tytuł:
The Methylation Analysis of the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Locus in GH-Secreting Pituitary Adenomas.
Autorzy:
Dalle Nogare M; Department of Biology, University of Padova, 35128 Padova, Italy.
D'Annunzio S; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, 38123 Trento, Italy.
Vazza G; Department of Biology, University of Padova, 35128 Padova, Italy.
Regazzo D; Endocrinology Unit, Department of Medicine, Padova University Hospital, 35121 Padova, Italy.
Picello L; Department of Biology, University of Padova, 35128 Padova, Italy.
Denaro L; Academic Neurosurgery, Department of Neurosciences, Padova University Hospital, 35121 Padova, Italy.
Voltan G; Endocrinology Unit, Department of Medicine, Padova University Hospital, 35121 Padova, Italy.
Scaroni C; Endocrinology Unit, Department of Medicine, Padova University Hospital, 35121 Padova, Italy.
Ceccato F; Endocrinology Unit, Department of Medicine, Padova University Hospital, 35121 Padova, Italy.
Occhi G; Department of Biology, University of Padova, 35128 Padova, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 25; Vol. 24 (11). Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Journal Article
MeSH Terms:
Adenoma*/genetics
Adenoma*/metabolism
Growth Hormone-Secreting Pituitary Adenoma*/genetics
Receptors, Gastrointestinal Hormone*/metabolism
Humans ; Decitabine ; DNA Methylation ; Epigenesis, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
Autorzy:
Tucker DW; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Pangal DJ; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Du R; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Gogia AS; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Tafreshi A; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Ruzevick J; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Hurth KT; Department of Clinical Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Triche T Jr; Center for Epigenetics, Van Andel Research Institute, Grand Rapids, Michigan, United States of America.
Micko A; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
Carpten JD; Department of Translational Genomics, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Shiroishi MS; Department of Radiology, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Carmichael JD; Department of Endocrinology, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Rhie SK; Department of Biochemistry and Molecular Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Zada G; USC Brain Tumor Center, Department of Neurosurgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 27; Vol. 18 (4), pp. e0284949. Date of Electronic Publication: 2023 Apr 27 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Adenoma*/pathology
Growth Hormone-Secreting Pituitary Adenoma*/genetics
Growth Hormone-Secreting Pituitary Adenoma*/complications
Human Growth Hormone*
Pituitary Neoplasms*/pathology
Humans ; Growth Hormone
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Caloric restriction as a possible pitfall for persistent acromegaly follow-up - case report.
Autorzy:
Martins AF; Endocrine Department, Hospital da Luz de Lisboa, Av Lusíada, Nr 100, 1500-650, Lisbon, Portugal. .
Santos M; Nutrition Department, Hospital da Luz de Lisboa, Av Lusíada, Nr 100, 1500-650, Lisbon, Portugal.
Rosário F; Endocrine Department, Hospital da Luz de Lisboa, Av Lusíada, Nr 100, 1500-650, Lisbon, Portugal.
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2023 Mar 27; Vol. 23 (1), pp. 68. Date of Electronic Publication: 2023 Mar 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Caloric Restriction*/adverse effects
Caloric Restriction*/methods
Growth Hormone-Secreting Pituitary Adenoma*/blood
Growth Hormone-Secreting Pituitary Adenoma*/diagnosis
Growth Hormone-Secreting Pituitary Adenoma*/surgery
Adenoma*/blood
Adenoma*/diagnosis
Adenoma*/surgery
Adult ; Female ; Humans ; Acromegaly/blood ; Acromegaly/diagnosis ; Acromegaly/surgery ; Follow-Up Studies ; Human Growth Hormone/blood ; Insulin-Like Growth Factor I/analysis ; Neoplasm Recurrence, Local/blood ; Neoplasm Recurrence, Local/etiology ; Reoperation ; Radiosurgery/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors.
Autorzy:
Yamato A; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nagano H; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Gao Y; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.
Matsuda T; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.
Hashimoto N; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan.
Nakayama A; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yamagata K; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yokoyama M; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Gong Y; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Shi X; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Zhahara SN; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kono T; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Taki Y; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Furuki N; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nishimura M; Division of Laboratory Medicine, Chiba University Hospital, Chiba, Japan.
Horiguchi K; Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.
Iwadate Y; Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.
Fukuyo M; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Rahmutulla B; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kaneda A; Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hasegawa Y; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.
Kawashima Y; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.
Ohara O; Department of Applied Genomics, Kazusa DNA Research Institute, Chiba, Japan.
Ishikawa T; Advanced Data Science Project, RIKEN Information R&D and Strategy Headquarters, RIKEN, Kanagawa, Japan.; Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Extended Intelligence for Medicine, The Ishii-Ishibashi Laboratory, Keio University School of Medicine, Tokyo, Japan.
Kawakami E; Advanced Data Science Project, RIKEN Information R&D and Strategy Headquarters, RIKEN, Kanagawa, Japan.; Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakamura Y; Division of Pathology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
Inoshita N; Department of Pathology, Moriyama Memorial Hospital, Tokyo, Japan.
Yamada S; Hypothalamic and Pituitary Center, Moriyama Neurological Center Hospital, Tokyo, Japan.
Fukuhara N; Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan.
Nishioka H; Department of Hypothalamic and Pituitary Surgery, Toranomon Hospital, Tokyo, Japan.
Tanaka T; Department of Molecular Diagnosis, Graduate School of Medicine, Chiba University, Chiba, Japan. .; Research Institute of Disaster Medicine, Chiba University, Chiba, Japan. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2022 Nov 27; Vol. 5 (1), pp. 1304. Date of Electronic Publication: 2022 Nov 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Somatotrophs*/metabolism
Somatotrophs*/pathology
Acromegaly*/complications
Acromegaly*/metabolism
Acromegaly*/pathology
Pituitary Neoplasms*/genetics
Pituitary Neoplasms*/metabolism
Pituitary Neoplasms*/pathology
Proteogenomics*
Neuroendocrine Tumors*/genetics
Neuroendocrine Tumors*/pathology
Adenoma*/genetics
Adenoma*/metabolism
Adenoma*/pathology
Growth Hormone-Secreting Pituitary Adenoma*/genetics
Growth Hormone-Secreting Pituitary Adenoma*/complications
Growth Hormone-Secreting Pituitary Adenoma*/pathology
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Comment on "Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal".
Autorzy:
Daly AF; Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Liège, Belgium.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Sep; Vol. 47 (9), pp. 1490. Date of Electronic Publication: 2022 Mar 21.
Typ publikacji:
Letter; Comment
MeSH Terms:
Acromegaly*/drug therapy
Adenoma*/drug therapy
Growth Hormone-Secreting Pituitary Adenoma*/complications
Growth Hormone-Secreting Pituitary Adenoma*/drug therapy
Humans ; Somatostatin/analogs & derivatives ; Somatostatin/therapeutic use
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Integrated Stress Response Is Tumorigenic and Constitutes a Therapeutic Liability in Somatotroph Adenomas.
Autorzy:
Li Z; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Chen Y; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Yao X; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.; Shanxi Provincial People's Hospital, Taiyuan 030000, China.
Liu Q; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Zhu H; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Zhang Y; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Feng J; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.
Gao H; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, China.; China National Clinical Research Center for Neurological Diseases, Beijing 100070, China.; Key Laboratory of Central Nervous System Injury Research, Beijing 100070, China.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Oct 28; Vol. 23 (21). Date of Electronic Publication: 2022 Oct 28.
Typ publikacji:
Journal Article
MeSH Terms:
Growth Hormone-Secreting Pituitary Adenoma*/genetics
Adenoma*/genetics
Adenoma*/metabolism
Acromegaly*
Pituitary Neoplasms*/metabolism
Humans ; Prokaryotic Initiation Factor-2 ; Carcinogenesis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Persistent remission of acromegaly in a patient with GH-secreting pituitary adenoma: Effect of treatment with pasireotide long-acting release and consequence of treatment withdrawal.
Autorzy:
Yu N; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Wang L; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Yang H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Pan H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Duan L; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Zhu H; Key Laboratory of Endocrinology of National Health Commission, Department of Endocrinology, State Key Laboratory of Complex Severe and Rare Diseases Peking, Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Jun; Vol. 47 (6), pp. 835-840. Date of Electronic Publication: 2022 Feb 15.
Typ publikacji:
Case Reports
MeSH Terms:
Acromegaly*/drug therapy
Adenoma*/chemically induced
Adenoma*/complications
Adenoma*/drug therapy
Growth Hormone-Secreting Pituitary Adenoma*/chemically induced
Growth Hormone-Secreting Pituitary Adenoma*/complications
Growth Hormone-Secreting Pituitary Adenoma*/drug therapy
Human Growth Hormone*/therapeutic use
Humans ; Insulin-Like Growth Factor I ; Male ; Middle Aged ; Octreotide ; Somatostatin/analogs & derivatives ; Somatostatin/therapeutic use ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Case report: acromegaly and breast cancer in a woman with turner syndrome.
Autorzy:
Naessén S; Department of Women's and Children's Health, Division of Obstetrics and Gynaecology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Landin-Wilhelmsen K; Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Section for Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology [Gynecol Endocrinol] 2021 Nov; Vol. 37 (11), pp. 1046-1049. Date of Electronic Publication: 2021 Aug 06.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Acromegaly*
Adenocarcinoma*
Breast Neoplasms*
Growth Hormone-Secreting Pituitary Adenoma*
Turner Syndrome*
Aged ; Female ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel somatic variants involved in biochemical activity of pure growth hormone-secreting pituitary adenoma without GNAS variant.
Autorzy:
Ku CR; Institute of Endocrine Research, Pituitary Tumor Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Lim H; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Lee YJ; Institute of Endocrine Research, Pituitary Tumor Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Kim SH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, South Korea.; Department of Neurosurgery, Ewha Womans University School of Medicine, Seoul, South Korea.
Kim D; Institute of Endocrine Research, Pituitary Tumor Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea.
Kim SH; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
Lee MK; Department of Pathology, National Health Insurance Service Ilsan Hospital, Gyeonggi-do, Republic of Korea.
Bang D; Department of Chemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Lee EJ; Institute of Endocrine Research, Pituitary Tumor Center, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Aug 16; Vol. 11 (1), pp. 16530. Date of Electronic Publication: 2021 Aug 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Genes, Neoplasm*
Adenoma/*genetics
Growth Hormone-Secreting Pituitary Adenoma/*genetics
Pituitary Neoplasms/*genetics
Adenoma/metabolism ; Adult ; Aged ; Animals ; Biomarkers, Tumor/genetics ; Carcinogenesis/genetics ; Cell Line, Tumor ; Chromogranins ; DNA, Neoplasm/genetics ; Female ; GTP-Binding Protein alpha Subunits, Gs ; Gene Ontology ; Genetic Association Studies ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Human Growth Hormone/metabolism ; Humans ; Male ; Middle Aged ; Pituitary Neoplasms/metabolism ; Rats ; Sequence Analysis, DNA ; Transfection ; Exome Sequencing ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma.
Autorzy:
Jung H; Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
Kim K; Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Kim D; Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Moon JH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.
Kim EH; Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.
Kim SH; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Ku CR; Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Lee EJ; Division of Endocrinology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2021 Apr; Vol. 36 (2), pp. 342-350. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromogranins*/genetics
GTP-Binding Protein alpha Subunits, Gs*/genetics
Growth Hormone-Secreting Pituitary Adenoma*/genetics
Growth Hormone-Secreting Pituitary Adenoma*/pathology
Growth Hormone-Secreting Pituitary Adenoma*/surgery
Female ; Humans ; Male ; Mutation ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Female pattern hair loss with acromegaly.
Autorzy:
Mizukami Y; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Sugawara K; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Tsuruta D; Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2021 Apr; Vol. 46 (3), pp. 607-609. Date of Electronic Publication: 2020 Oct 14.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Acromegaly/*complications
Alopecia/*etiology
Growth Hormone-Secreting Pituitary Adenoma/*complications
Acromegaly/diagnostic imaging ; Adult ; Alopecia/pathology ; Female ; Growth Hormone-Secreting Pituitary Adenoma/diagnostic imaging ; Growth Hormone-Secreting Pituitary Adenoma/surgery ; Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Up-regulation of sex-determining region Y-box 9 (SOX9) in growth hormone-secreting pituitary adenomas.
Autorzy:
Shirian FI; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ghorbani M; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran. .
Khamseh ME; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Imani M; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Panahi M; Firozgar Hospital, Pathology Department, Iran University of Medical Sciences, Tehran, Iran.
Alimohammadi A; Iranian Legal Medicine Organizations, Tehran, Iran.
Nourbakhsh M; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
Salimi V; Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Tavakoli-Yaraki M; Department of Biochemistry, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2021 Mar 18; Vol. 21 (1), pp. 50. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article
MeSH Terms:
Adenoma/*genetics
Growth Hormone-Secreting Pituitary Adenoma/*genetics
SOX9 Transcription Factor/*genetics
Acromegaly/genetics ; Acromegaly/metabolism ; Acromegaly/pathology ; Adenoma/metabolism ; Adenoma/pathology ; Adult ; Aged ; Case-Control Studies ; Female ; Gene Expression Regulation, Neoplastic ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; SOX9 Transcription Factor/metabolism ; Up-Regulation/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Association of an empty sella and grave´s disease in a patient with acromegaly: a case report.
Autorzy:
Halloul I; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Abdelkerim AB; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Saad G; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Slim A; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Hasni Y; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Othman WB; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Kacem M; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Chaieb M; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Maaroufi A; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Ach K; Endocrinology and Diabetes Department, Farhat Hached University Hospital, Sousse, Tunisia.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2021 Apr 22; Vol. 38, pp. 394. Date of Electronic Publication: 2021 Apr 22 (Print Publication: 2021).
Typ publikacji:
Case Reports
MeSH Terms:
Acromegaly/*diagnosis
Empty Sella Syndrome/*diagnostic imaging
Graves Disease/*diagnostic imaging
Growth Hormone-Secreting Pituitary Adenoma/*diagnostic imaging
Antithyroid Agents/administration & dosage ; Diabetes Mellitus/physiopathology ; Female ; Growth Hormone-Secreting Pituitary Adenoma/surgery ; Humans ; Hyperthyroidism/diagnosis ; Hyperthyroidism/drug therapy ; Insulin-Like Growth Factor I/metabolism ; Magnetic Resonance Imaging ; Middle Aged ; Thyrotropin/metabolism
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
[Acromegaly and it's cardiovascular implications].
Autorzy:
Cadena-Obando DA; Centro Médico ABC, Campus Observatorio, Servicio de Endocrinología, Ciudad de México, México.
Remba-Shapiro I; Universidad Anáhuac, Facultad de Medicina, Servicio Rotatorio de Pregrado, Ciudad de México, México.
Abreu-Rosario CG; Centro Médico ABC, Campus Observatorio, Servicio de Endocrinología, Ciudad de México, México.
Mercado M; Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades Dr. Bernardo Sepúlveda Gutiérrez, Unidad de Investigación Médica en Enfermedades Endócrinas, Ciudad de México, México.
Pokaż więcej
Transliterated Title:
Acromegalia y sus implicaciones cardiovasculares.
Źródło:
Revista medica del Instituto Mexicano del Seguro Social [Rev Med Inst Mex Seguro Soc] 2021 Feb 02; Vol. 59 (1), pp. 73-80. Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Acromegaly*/complications
Acromegaly*/diagnosis
Adenoma*
Growth Hormone-Secreting Pituitary Adenoma*
Human Growth Hormone/*metabolism
Insulin-Like Growth Factor I/*metabolism
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy and safety of lanreotide autogel compared with lanreotide 40 mg prolonged release in Chinese patients with active acromegaly: results from a phase 3, prospective, randomized, and open-label study (LANTERN).
Autorzy:
An Z; West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lei T; Tongji Hospital, Tongji Medical college of HUST, Wuhan, China.
Duan L; Peking Union Medical College Hospital, PUMCH, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Hu P; Peking Union Medical College Hospital, PUMCH, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China.
Gou Z; West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang L; The second hospital of Hebei Medical University, Shijiazhuang, China.
Durand-Gasselin L; Ipsen Innovation, Les Ulis, France.
Wang N; Ipsen Pharma, Beijing, China.
Wang Y; Ipsen Pharma, Beijing, China.
Gu F; Peking Union Medical College Hospital, PUMCH, No.1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing, 100730, China. .
Pokaż więcej
Corporate Authors:
LANTERN study investigators
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2020 May 04; Vol. 20 (1), pp. 57. Date of Electronic Publication: 2020 May 04.
Typ publikacji:
Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article
MeSH Terms:
Adenoma/*drug therapy
Antineoplastic Agents/*administration & dosage
Growth Hormone-Secreting Pituitary Adenoma/*drug therapy
Peptides, Cyclic/*administration & dosage
Somatostatin/*analogs & derivatives
Adenoma/diagnostic imaging ; Adenoma/metabolism ; Adenoma/pathology ; Adult ; Antineoplastic Agents/therapeutic use ; Blood Glucose/metabolism ; China ; Delayed-Action Preparations ; Female ; Glycated Hemoglobin/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/diagnostic imaging ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Human Growth Hormone/metabolism ; Humans ; Injections, Intramuscular ; Injections, Subcutaneous ; Insulin-Like Growth Factor I/metabolism ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Peptides, Cyclic/therapeutic use ; Somatostatin/administration & dosage ; Somatostatin/therapeutic use ; Treatment Outcome ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Therapeutic Effect of a Novel Chimeric Molecule Targeting Both Somatostatin and Dopamine Receptors on Growth Hormone-Secreting Pituitary Adenomas.
Autorzy:
Kim J; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.; Endocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
Oh JH; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.; Endocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea.
Harlem H; Endocrinology Research, Ipsen Bioscience Inc., Cambridge, MA, USA.
Culler MD; Endocrinology Research, Ipsen Bioscience Inc., Cambridge, MA, USA.
Ku CR; Endocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea. .
Lee EJ; Brain Korea 21 PLUS Project for Medical Science, Yonsei University, Seoul, Korea.; Endocrinology, Institute of Endocrine Research, Yonsei University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło:
Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2020 Mar; Vol. 35 (1), pp. 177-187.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenoma/*drug therapy
Dopamine/*pharmacology
Gene Expression Regulation, Neoplastic/*drug effects
Growth Hormone-Secreting Pituitary Adenoma/*drug therapy
Intracellular Signaling Peptides and Proteins/*physiology
Receptors, Dopamine/*chemistry
Receptors, Somatostatin/*antagonists & inhibitors
Somatostatin/*pharmacology
Adenoma/metabolism ; Adenoma/pathology ; Animals ; Cell Proliferation ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Rats ; Tumor Cells, Cultured
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Somatostatin Analogs in Clinical Practice: a Review.
Autorzy:
Gomes-Porras M; Department of Endocrinology, 'La Paz' University Hospital. Paseo de la Castellana, 261, 28046 Madrid, Spain.
Cárdenas-Salas J; Department of Endocrinology, 'Fundación Jiménez-Diaz' University Hospital. Av. de los Reyes Católicos, 2, 28040 Madrid, Spain.
Álvarez-Escolá C; Department of Endocrinology, 'La Paz' University Hospital. Paseo de la Castellana, 261, 28046 Madrid, Spain.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2020 Feb 29; Vol. 21 (5). Date of Electronic Publication: 2020 Feb 29.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antineoplastic Agents, Hormonal/*therapeutic use
Growth Hormone-Secreting Pituitary Adenoma/*drug therapy
Intestinal Neoplasms/*drug therapy
Neuroendocrine Tumors/*drug therapy
Pancreatic Neoplasms/*drug therapy
Somatostatin/*therapeutic use
Stomach Neoplasms/*drug therapy
Diabetic Retinopathy/drug therapy ; Diabetic Retinopathy/pathology ; Graves Ophthalmopathy/drug therapy ; Graves Ophthalmopathy/pathology ; Growth Hormone-Secreting Pituitary Adenoma/genetics ; Growth Hormone-Secreting Pituitary Adenoma/pathology ; Humans ; Intestinal Neoplasms/genetics ; Intestinal Neoplasms/pathology ; Macular Edema/drug therapy ; Macular Edema/pathology ; Neuroendocrine Tumors/genetics ; Neuroendocrine Tumors/pathology ; Pancreatic Neoplasms/genetics ; Pancreatic Neoplasms/pathology ; Pituitary Neoplasms/drug therapy ; Pituitary Neoplasms/pathology ; Somatostatin/analogs & derivatives ; Somatostatin/genetics ; Stomach Neoplasms/genetics ; Stomach Neoplasms/pathology
SCR Disease Name:
Gastro-enteropancreatic neuroendocrine tumor
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Impact of SLC20A1 on the Wnt/β‑catenin signaling pathway in somatotroph adenomas.
Autorzy:
Li J; Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, P.R. China.
Dong W; Department of Neurosurgery, Tangshan People's Hospital, Tangshan, Hebei 063001, P.R. China.
Li Z; Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, P.R. China.
Wang H; Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, P.R. China.
Gao H; Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, P.R. China.
Zhang Y; Key Laboratory of Central Nervous System Injury Research, Beijing Neurosurgical Institute, Capital Medical University, Beijing 100070, P.R. China.
Pokaż więcej
Źródło:
Molecular medicine reports [Mol Med Rep] 2019 Oct; Vol. 20 (4), pp. 3276-3284. Date of Electronic Publication: 2019 Aug 06.
Typ publikacji:
Journal Article
MeSH Terms:
Adenoma*/metabolism
Adenoma*/mortality
Adenoma*/pathology
Gene Expression Regulation, Neoplastic*
Growth Hormone-Secreting Pituitary Adenoma*/metabolism
Growth Hormone-Secreting Pituitary Adenoma*/mortality
Growth Hormone-Secreting Pituitary Adenoma*/pathology
Wnt Signaling Pathway*
Neoplasm Proteins/*metabolism
Sodium-Phosphate Cotransporter Proteins, Type III/*biosynthesis
Adolescent ; Adult ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Survival Rate ; beta Catenin/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Preoperative Somatostatin Analogues in Patients with Newly-diagnosed Acromegaly: A Systematic Review and Meta-analysis of Comparative Studies.
Autorzy:
Yang C; Department of Neurosurgery, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Li G; Department of Endocrinology, Key Laboratory of Endocrinology of Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Jiang S; Department of Neurosurgery, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Bao X; Department of Neurosurgery, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China. .
Wang R; Department of Neurosurgery, China Pituitary Disease Registry Center, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Oct 01; Vol. 9 (1), pp. 14070. Date of Electronic Publication: 2019 Oct 01.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Acromegaly/*drug therapy
Growth Hormone-Secreting Pituitary Adenoma/*drug therapy
Somatostatin/*analogs & derivatives
Acromegaly/surgery ; Combined Modality Therapy ; Growth Hormone-Secreting Pituitary Adenoma/surgery ; Humans ; Somatostatin/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of the thyroid characteristics of patients with growth hormone-secreting adenomas.
Autorzy:
Xu D; Department of Neurosurgery, The First Affiliated Hospital, Jinan University, No. 613 Huangpu Avenue West, Tianhe District, Guangzhou 510632, Guangdong Province, 510630, People's Republic of China.
Wu B; Department of Neurosurgery, The First Affiliated Hospital, Jinan University, No. 613 Huangpu Avenue West, Tianhe District, Guangzhou 510632, Guangdong Province, 510630, People's Republic of China.
Li X; Department of Medical Ultrasound, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510632, China.
Cheng Y; Department of cardiology, The First Affiliated Hospital, SunYat-sen University, Guangzhou, 510632, China.
Chen D; Department of laboratory medicine, The first affiliated hospital, Sun Yat-sen university, Guangzhou, 510632, China.
Fang Y; Asset Management Division, Guangdong University of Foreign Studies, Guangzhou, 510420, China.
Du Q; Department of Neurosurgery, The Affiliated Hospital of Yangzhou University, Yangzhou, 225012, China.
Chen Z; Department of Neurosurgery, The First Affiliated Hospital, Jinan University, No. 613 Huangpu Avenue West, Tianhe District, Guangzhou 510632, Guangdong Province, 510630, People's Republic of China. .
Wang X; Department of Neurosurgery, The First Affiliated Hospital, Jinan University, No. 613 Huangpu Avenue West, Tianhe District, Guangzhou 510632, Guangdong Province, 510630, People's Republic of China. .
Pokaż więcej
Źródło:
BMC endocrine disorders [BMC Endocr Disord] 2019 Sep 02; Vol. 19 (1), pp. 94. Date of Electronic Publication: 2019 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Adenoma/*physiopathology
Growth Hormone-Secreting Pituitary Adenoma/*physiopathology
Human Growth Hormone/*metabolism
Thyroid Diseases/*epidemiology
Thyroid Hormones/*metabolism
Thyroid Nodule/*pathology
Adenoma/metabolism ; Adult ; Aged ; Female ; Follow-Up Studies ; Growth Hormone-Secreting Pituitary Adenoma/metabolism ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Taiwan/epidemiology ; Thyroid Diseases/diagnosis ; Thyroid Diseases/diagnostic imaging ; Thyroid Diseases/metabolism ; Thyroid Nodule/diagnostic imaging ; Thyroid Nodule/metabolism ; Ultrasonography ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 263

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies